Charles River Laboratories Total Liabilities and Share Holders Equity 2010-2025 | CRL
Charles River Laboratories total liabilities and share holders equity for the quarter ending March 31, 2025 was $7.582B, a 7% decline year-over-year.
- Charles River Laboratories total liabilities and share holders equity for 2024 was $7.528B, a 8.13% decline from 2023.
- Charles River Laboratories total liabilities and share holders equity for 2023 was $8.195B, a 7.79% increase from 2022.
- Charles River Laboratories total liabilities and share holders equity for 2022 was $7.603B, a 8.24% increase from 2021.